What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **How to standardize the assessment of the engraftment extent of the microbiota after fecal microbiota transplant (FMT)**. Specifically, researchers hope to develop a comprehensive and consistent method to quantify the changes in the recipient microbiota after FMT in order to determine whether FMT is successful and its therapeutic effect. ### Problem Background FMT is a treatment method that transplants the fecal microbiota of a healthy donor into a patient to restore or reconstruct the patient's gut microbiota. Although FMT has shown significant efficacy in certain diseases (such as recurrent Clostridium difficile infection), the current methods for assessing the engraftment extent of the microbiota after FMT are not standardized. This makes it difficult for researchers to determine whether FMT is effective for a specific disease or whether the reason for failure is that the microbiota fails to engraft successfully. ### Solution To this end, the authors developed a QIIME 2 plugin named **q2 - fmt**, which provides multiple methods to assess the engraftment extent of the microbiota after FMT. These methods cover the following aspects: 1. **Chimeric Asymmetric Community Coalescence (CACC)**: - Quantify the degree of transformation of the recipient microbiota composition towards the donor microbiota composition after FMT. - Use "raincloud plots" and related statistical analysis to track the changes in the microbiota composition over time. 2. **Donated Microbiome Indicator Features (DMIF)**: - Track the presence of specific features in the donor microbiota (such as specific amplicon sequence variants or genera of interest) in the recipient microbiota. - Identify significantly over - expressed features in the donor microbiota by methods such as ANCOMBC (Analysis of Composition of Microbiomes with Bias Correction). 3. **Temporal Stability**: - Track the temporal stability of the microbiota after FMT, that is, the degree to which the recipient microbiota maintains similarity to the donor microbiota. - Evaluate the long - term impact of the microbiota after FMT through longitudinal data analysis. ### Method Implementation - **Chimeric Asymmetric Community Coalescence (CACC)**: - Use the `qiime fmt cc` command to generate "raincloud plots" and calculate the changes in the microbiota composition over time. - Inputs include alpha - diversity or beta - diversity metrics (QIIME 2 semantic types: `SampleData[AlphaDiversity]` or `DistanceMatrix`). - **Proportional Engraftment of Donor Features (PEDF)**: - Calculate the proportion of donor features in the recipient sample. The formula is as follows: \[ PEDF=\frac{\text{The number of donor features observed in the recipient sample}}{\text{The total number of donor features}} \] - Provide heat maps and raincloud plots to visualize the changes in PEDF over time. - **Proportion of Recipients with Donor Feature (PRDF)**: - Defined as the proportion of recipients that successfully engraft a specific feature. The formula is as follows: \[ PRDF = \frac{\text{The number of recipients that engraft a certain feature}}{\text{The number of recipients that contain this feature in the donor}} \] - **Proportion of Persistent Recipient Features (PPRF)**: - Calculate the proportion that still exists after FMT.

Assessing microbiome engraftment extent following fecal microbiota transplant with q2-fmt

Assessing Engraftment Following Fecal Microbiota Transplant

Assessing the viability of transplanted gut microbiota by sequential tagging with D-amino acid-based metabolic probes

Detecting microbial engraftment after FMT: sorting signals from noise using placebo sequencing and culture-enriched metagenomics

High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization.

q2-metnet: QIIME2 package to analyze 16S rRNA data via high-quality metabolic reconstructions of the human gut microbiota

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation

Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases

High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria

In Silico Analysis of Changes in Predicted Metabolic Capabilities of Intestinal Microbiota after Fecal Microbial Transplantation for Treatment of Recurrent Clostridioides difficile Infection

Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin

Facilitating bootstrapped and rarefaction-based microbiome diversity analysis with q2-boots

The Establishment and Composition of Donor-Like Gut Microbial Community after Faecal Microbiota Transplant in Sepsis

Novel Microbial Engraftment Trajectories following Microbiota Transplantation Therapy in Ulcerative Colitis

LongTrack: long read metagenomics-based precise tracking of bacterial strains and their genomic changes after fecal microbiota transplantation

Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation

Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease

Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease

The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation